Janssen Pharmaceutica

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: -

Established: 1953-01-01

Employees: 10K

Market Cap: -

Website: http://www.janssenpharmaceutica.be/

Clinical Trials

Contineum Therapeutics Completes Enrollment in Phase 2 Trial of PIPE-307 for Relapsing-Remitting Multiple Sclerosis

5 months ago

Contineum Therapeutics has completed enrollment of 168 patients in its Phase 2 VISTA trial evaluating PIPE-307 for relapsing-remitting multiple sclerosis (RRMS).

Home Terms & Conditions Privacy Policy